Journal
JOURNAL OF IMMUNOLOGY
Volume 179, Issue 10, Pages 6973-6980Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.179.10.6973
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01-HL063655] Funding Source: Medline
- NIAID NIH HHS [K08-AI064014] Funding Source: Medline
Ask authors/readers for more resources
The factors that contribute to the exceptionally high incidence of Mycobacterium tuberculosis (MTb) disease in HIV+ persons are poorly understood. Macrophage apoptosis represents a critical innate host cell response to control MTb infection and limit disease. In the current study, virulent live or irradiated MTb (iMTbRv) induced apoptosis of differentiated human U937 macrophages in vitro, in part dependent on TNF-alpha. In contrast, apoptosis of differentiated HIV+ human U1 macrophages (HIV+ U937 subclone) was markedly reduced in response to iMTbRv and associated with significantly reduced TNF-a release, whereas apoptosis and TNF-a release were intact to TLR-independent stimuli. Furthermore, reduced macrophage apoptosis and TNF-a release were independent of MTb phagocytosis.'Whereas surface expression of macrophage TLR2 and TLR4 was preserved, IL-1 receptor associated kinase-1 phosphorylation and NF-kappa B nuclear translocation were reduced in HIV+ U1 macrophages in response to iMTbRv. These findings were confirmed using clinically relevant human alveolar macrophages (AM) from healthy persons and asymptomatic HIV+ persons at clinical risk for MTb infection. Furthermore, in vitro HIV infection of AM from healthy persons reduced both TNF-a release and AM apoptosis in response to iMTbRv. These data identify an intrinsic specific defect in a critical macrophage cellular response to MTb that may contribute to disease pathogenesis in HIV+ persons.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available